Opinions and experiences in general practice on osteoporosis prevention, diagnosis and management

被引:54
作者
Taylor, JC
Sterkel, B
Utley, M
Shipley, M
Newman, S
Horton, M
Fitz-Clarence, H
机构
[1] UCL Hosp, Ctr Rheumatol, London W1T 4NJ, England
[2] Washington Univ Hosp, St Louis, MO USA
[3] UCL, Clin Operat Res Unit, London, England
[4] UCL, Unit Hlth Psychol, London, England
[5] UCL, Bone & Mineral Ctr, London, England
关键词
general practice; medical education; osteoporosis;
D O I
10.1007/s001980170035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined to survey the general practice population regarding their attitudes to and knowledge of osteoporosis as a baseline prior to publication of national guidelines for the management of osteoporosis. All 2515 general practitioners registered in the 10 Health Authorities of the North Thames region, London, UK were surveyed by a postal questionnaire. Responses relating to epidemiology, public health and education on osteoporosis were analyzed. The overall response was 1153 (46%). General practitioners who responded were younger, predominantly female and in group practice. There is considerable awareness of the importance of preventing osteoporosis. General practitioners are active in identifying groups at risk, particularly those who are aged 40 years and older. A prevention strategy for osteoporosis is viewed as effective. However, two thirds of general practitioners remain unconvinced about the efficacy of drug therapy. Education on osteoporosis is considered inadequate. General practitioners would welcome further information on management issues and access to osteoporosis services. In conclusion, educational initiatives will be important both at undergraduate and postgraduate levels to increase awareness and knowledge of osteoporosis. General practitioners are aware of the public health impact of this condition and express a preference for educational material of direct relevance to the care of their patients. Therefore better cooperation between primary and secondary care should lead to ways of breaking down barriers to change in clinical practice and promoting fully integrated care of patients with osteoporosis.
引用
收藏
页码:844 / 848
页数:5
相关论文
共 23 条
[1]  
ALTMAN DG, 1991, PRACTICAL STAT MED R, P233
[2]  
BARLOW D, 1999, OSTEOPOROSIS CLIN GU
[3]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]  
COOPER C, 1992, OSTEOPOROSIS INT, V2, P258
[6]   Monitoring individual response to hormone replacement therapy with bone markers [J].
Delmas, PD ;
Hardy, P ;
Garnero, P ;
Dain, MP .
BONE, 2000, 26 (06) :553-560
[7]   The cost of treating osteoporotic fractures in the United Kingdom female population [J].
Dolan, P ;
Togerson, DJ .
OSTEOPOROSIS INTERNATIONAL, 1998, 8 (06) :611-617
[8]   Treatment of postmenopausal osteoporosis [J].
Eastell, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :736-746
[9]   Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].
Ettinger, B ;
Black, DM ;
Mitlak, BH ;
Knickerbocker, RK ;
Nickelsen, T ;
Genant, HK ;
Christiansen, C ;
Delmas, PD ;
Zanchetta, JR ;
Stakkestad, J ;
Glüer, CC ;
Krueger, K ;
Cohen, FJ ;
Eckert, S ;
Ensrud, KE ;
Avioli, LV ;
Lips, P ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645
[10]  
FREEMANTLE N, 1999, COCHRANE LIB